Skip to main content

Advertisement

SpringerLink
Log in

Path to clinical transplantation tolerance and prevention of graft-versus-host disease

  • IMMUNOLOGY AT STANFORD UNIVERSITY
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Although organ and bone marrow transplantations are life-saving procedures for patients with terminal diseases, the requirement for the lifelong use of immunosuppressive drugs to prevent organ graft rejection and the development of graft versus host disease (GVHD) remain important problems. Experimental approaches to solve these problems, first in preclinical models and then in clinical studies, developed at Stanford during the past 40 years are summarized in this article. The approaches use fractionated radiation of the lymphoid tissues, a procedure initially developed to treat Hodgkin’s disease, to alter the immune system such that tolerance to organ transplants can be achieved and GVHD can be prevented after the establishment of chimerism. In both instances, the desired goal was achieved when the balance of immune cells was changed to favor regulatory innate and adaptive immune cells that suppress the conventional immune cells that ordinarily promote inflammation and tissue injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature. 1953;172:603–6.

    Article  CAS  PubMed  Google Scholar 

  2. Hume DM, Egdahl RH. Progressive destruction of renal homografts isolated from the regional lymphatics of the host. Surgery. 1955;38:194–214.

    CAS  PubMed  Google Scholar 

  3. Gowans JL. The fate of parental strain small lymphocytes in F1 hybrid rats. Ann N Y Acad Sci. 1962;99:432–55.

    Article  CAS  PubMed  Google Scholar 

  4. Gowans JL, Knight EJ. The route of re-circulation of lymphocytes in the rat. Proc R Soc Lond B Biol Sci. 1964;159:257–82.

    Article  CAS  PubMed  Google Scholar 

  5. Marchesi VT, Gowans JL. The migration of lymphocytes through the endothelium of venules in lymph nodes: an electron microscope study. Proc R Soc Lond B Biol Sci. 1964;159:283–90.

    Article  CAS  PubMed  Google Scholar 

  6. Strober S, Gowans JL. The role of lymphocytes in the sensitization of rats to renal homografts. J Exp Med. 1965;122:347–60.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Zan-Bar I, Strober S, Vitetta ES. The relationship between surface immunoglobulin isotype and immune function of murine B lymphocytes. I. Surface immunoglobulin isotypes on primed B cells in the spleen. J Exp Med. 1977;145:1188–205.

    Article  CAS  PubMed  Google Scholar 

  8. Slavin S, Strober S. Spontaneous murine B-cell leukaemia. Nature. 1978;272:624–6.

    Article  CAS  PubMed  Google Scholar 

  9. Knapp MR, Jones PP, Black SJ, Vitetta ES, Slavin S, Strober S. Characterization of a spontaneous murine B cell leukemia (BCL1). I. Cell surface expression of IgM, IgD, Ia, and FcR. J Immunol. 1979;123:992–9.

    CAS  PubMed  Google Scholar 

  10. Strober S, Gronowicz ES, Knapp MR, Slavin S, Vitetta ES, Warnke RA, et al. Immunobiology of a spontaneous murine B cell leukemia (BCL1). Immunol Rev. 1979;48:169–95.

    Article  CAS  PubMed  Google Scholar 

  11. Knapp MR, Liu CP, Newell N, Ward RB, Tucker PW, Strober S, et al. Simultaneous expression of immunoglobulin mu and delta heavy chains by a cloned B-cell lymphoma: a single copy of the VH gene is shared by two adjacent CH genes. Proc Natl Acad Sci U S A. 1982;79:2996–3000.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Kaplan HS. Hodgkin’s Disease. Harvard University Press, Cambridge, Mass. 1972:89–104, 279–316.

  13. Levy R, Kaplan HS. Impaired lymphocyte function in untreated Hodgkin’s disease. N Engl J Med. 1974;290:181–6.

    Article  CAS  PubMed  Google Scholar 

  14. Fuks Z, Strober S, Bobrove AM, Sasazuki T, McMichael A, Kaplan HS. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin’s disease. J Clin Investig. 1976;58:803–14.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981;305:1425–31.

    Article  CAS  PubMed  Google Scholar 

  16. Slavin S, Strober S, Fuks Z, Kaplan HS. Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation. Science. 1976;193:1252–4.

    Article  CAS  PubMed  Google Scholar 

  17. Slavin S, Strober S, Fuks Z, Kaplan HS. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med. 1977;146:34–48.

    Article  CAS  PubMed  Google Scholar 

  18. Slavin S, Reitz B, Bieber CP, Kaplan HS, Strober S. Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts. J Exp Med. 1978;147:700–7.

    Article  CAS  PubMed  Google Scholar 

  19. Slavin S, Fuks Z, Kaplan HS, Strober S. Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation. J Exp Med. 1978;147:963–72.

    Article  CAS  PubMed  Google Scholar 

  20. Woodley SL, Gurley KE, Hoffmann SL, Nicolls MR, Hagberg R, Clayberger C, et al. Induction of tolerance to heart allografts in rats using posttransplant total lymphoid irradiation and anti-T cell antibodies. Transplantation. 1993;56:1443–7.

    Article  CAS  PubMed  Google Scholar 

  21. Hayamizu K, Lan F, Huie P, Sibley RK, Strober S. Comparison of chimeric acid and non-chimeric tolerance using posttransplant total lymphoid irradiation: cytokine expression and chronic rejection. Transplantation. 1999;68:1036–44.

    Article  CAS  PubMed  Google Scholar 

  22. Higuchi M, Zeng D, Shizuru J, Gworek J, Dejbakhsh-Jones S, Taniguchi M, et al. Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion. J Immunol. 2002;169:5564–70.

    Article  CAS  PubMed  Google Scholar 

  23. Lan F, Hayamizu K, Strober S. Cyclosporine facilitates chimeric and inhibits nonchimeric tolerance after posttransplant total lymphoid irradiation. Transplantation. 2000;69:649–55.

    Article  CAS  PubMed  Google Scholar 

  24. Liu YP, Li Z, Nador RG, Strober S. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells. Transplantation. 2008;85:607–14.

    Article  PubMed  Google Scholar 

  25. Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Sachs DH. Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med. 1985;162:231–44.

    Article  CAS  PubMed  Google Scholar 

  26. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med. 1989;169:493–502.

    Article  CAS  PubMed  Google Scholar 

  27. Pillai AB, George TI, Dutt S, Teo P, Strober S. Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation. J Immunol. 2007;178:6242–51.

    Article  CAS  PubMed  Google Scholar 

  28. Lan F, Zeng D, Huie P, Higgins JP, Strober S. Allogeneic bone marrow cells that facilitate complete chimerism and eliminate tumor cells express both CD8 and T-cell antigen receptor-alpha beta. Blood. 2001;97:3458–65.

    Article  CAS  PubMed  Google Scholar 

  29. Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, et al. CD4 + CD25 + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med. 2003;9:1144–50.

    Article  CAS  PubMed  Google Scholar 

  30. Slavin S, Strober S. Induction of allograft tolerance after total lymphoid irradiation (TLI): development of suppressor cells of the mixed leukocyte reaction (MLR). J Immunol. 1979;123:942–6.

    CAS  PubMed  Google Scholar 

  31. King DP, Strober S, Kaplan HS. Suppression of the mixed leukocyte response and of graft-vs-host disease by spleen cells following total lymphoid irradiation (TLI). J Immunol. 1981;126:1140–5.

    CAS  PubMed  Google Scholar 

  32. King DP, Strober S. Immunoregulatory changes induced by total lymphoid irradiation. II. Development of thymus-leukemia antigen-positive and -negative suppressor T cells that differ in their regulatory function. J Exp Med. 1981;154:13–23.

    Article  CAS  PubMed  Google Scholar 

  33. Okada S, Strober S. Spleen cells from adult mice given total lymphoid irradiation or from newborn mice have similar regulatory effects in the mixed leukocyte reaction. I. Generation of antigen-specific suppressor cells in the mixed leukocyte reaction after the addition of spleen cells from adult mice given total lymphoid irradiation. J Exp Med. 1982;156:522–38.

    Article  CAS  PubMed  Google Scholar 

  34. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol. 1997;15:535–62.

    Article  CAS  PubMed  Google Scholar 

  35. Kronenberg M, Engel I. On the road: progress in finding the unique pathway of invariant NKT cell differentiation. Curr Opin Immunol. 2007;19:186–93.

    Article  CAS  PubMed  Google Scholar 

  36. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, et al. Foxp3 + CD25 + CD4 + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006;212:8–27.

    Article  CAS  PubMed  Google Scholar 

  37. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol. 2003;3:199–210.

    Article  CAS  PubMed  Google Scholar 

  38. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9:162–74.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Garcia MR, Ledgerwood L, Yang Y, Xu J, Lal G, Burrell B, et al. Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J Clin Investig. 2010;120:2486–96.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. Lan F, Zeng D, Higuchi M, Huie P, Higgins JP, Strober S. Predominance of NK1.1 + TCR alpha beta + or DX5 + TCR alpha beta + T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: “natural suppressor” cells. J Immunol. 2001;167:2087–96.

    Article  CAS  PubMed  Google Scholar 

  41. Higuchi M, Zeng D, Shizuru J, Gworek J, Dejbakhsh-Jones S, Taniguchi M, et al. Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion. J Immunol. 2002;169:5564–70.

    Article  CAS  PubMed  Google Scholar 

  42. Lan F, Zeng D, Higuchi M, Higgins JP, Strober S. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells. Biol Blood Marrow Transpl. 2003;9:355–63.

    Article  Google Scholar 

  43. Nador RG, Hongo D, Baker J, Yao Z, Strober S. The changed balance of regulatory and naive T cells promotes tolerance after TLI and anti-T-cell antibody conditioning. Am J Transpl. 2010;10:262–72.

    Article  CAS  Google Scholar 

  44. Hongo D, Tang X, Dutt S, Nador RG, Strober S. Interactions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants. Blood. 2012;119:1581–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Pillai AB, George TI, Dutt S, Strober S. Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4 + CD25 + Foxp3 + T regulatory cells that protects against graft-versus-host disease. Blood. 2009;113:4458–67.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  46. Hongo D, Tang, X, Baker, J., Strober, S. Requirement for interactions of natural killer T Cells and myeloid derived Suppressor cells for transplantation tolerance. Am J Transpl (submitted). 2014.

  47. Ferrara JL, Levy R, Chao NJ. Pathophysiologic mechanisms of acute graft-vs.-host disease. Biol Blood Marrow Transpl. 1999;5:347–56.

    Article  CAS  Google Scholar 

  48. Palathumpat V, Dejbakhsh-Jones S, Holm B, Strober S. Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease. J Immunol. 1992;149:808–17.

    CAS  PubMed  Google Scholar 

  49. Palathumpat V, Holm B, Dejbakhsh-Jones S, Strober S. Treatment of BCL1 leukemia by transplantation of low density fractions of allogeneic bone marrow and spleen cells. J Immunol. 1992;148:3319–26.

    CAS  PubMed  Google Scholar 

  50. Zeng D, Lewis D, Dejbakhsh-Jones S, Lan F, Garcia-Ojeda M, Sibley R, et al. Bone marrow NK1.1(−) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med. 1999;189:1073–81.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  51. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196:389–99.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  52. Chaidos A, Patterson S, Szydlo R, Chaudhry MS, Dazzi F, Kanfer E, et al. Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Blood. 2012;119:5030–6.

    Article  CAS  PubMed  Google Scholar 

  53. Rubio MT, Moreira-Teixeira L, Bachy E, Bouillie M, Milpied P, Coman T, et al. Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival. Blood. 2012;120:2144–54.

    Article  CAS  PubMed  Google Scholar 

  54. Lowsky R, Takahashi T, Liu YP, Dejbakhsh-Jones S, Grumet FC, Shizuru JA, et al. Protective conditioning for acute graft-versus-host disease. N Engl J Med. 2005;353:1321–31.

    Article  CAS  PubMed  Google Scholar 

  55. Kohrt HE, Turnbull BB, Heydari K, Shizuru JA, Laport GG, Miklos DB, et al. TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. Blood. 2009;114:1099–109.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  56. Messina G, Giaccone L, Festuccia M, Irrera G, Scortechini I, Sorasio R, et al. Multicenter experience using total lymphoid irradiation and antithymocyte globulin as conditioning for allografting in hematological malignancies. Biol Blood Marrow Transpl. 2012;18:1600–7.

    Article  Google Scholar 

  57. Cecka JM. The UNOS scientific renal transplant registry–ten years of kidney transplants. Clin Transpl. 1997;57:1–14.

    Google Scholar 

  58. Field EH, Strober S. Tolerance, mixed chimerism and protection against GVHD after TLI. Philos Trans R Soc Lond B Biol Sci. 2001;356:1–10.

    Article  Google Scholar 

  59. Strober S, Spitzer TR, Lowsky R, Sykes M. Translational studies in hematopoietic cell transplantation: treatment of hematologic malignancies as a stepping stone to tolerance induction. Semin Immunol. 2011;23:273–81.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  60. Hunt SA, Strober S, Hoppe RT, Stinson EB. Total lymphoid irradiation for treatment of intractable cardiac allograft rejection. J Heart Lung Transpl. 1991;10:211–6.

    CAS  Google Scholar 

  61. Tallaj JA, Pamboukian SV, George JF, Brown RN, Pajaro OE, Bourge RC, et al. Total lymphoid irradiation in heart transplantation: long-term efficacy and survival–an 18-year experience. Transplantation. 2011;92:1159–64.

    Article  PubMed  Google Scholar 

  62. Strober S, Modry DL, Hoppe RT, Pennock JL, Bieber CP, Holm BI, et al. Induction of specific unresponsiveness to heart allografts in mongrel dogs treated with total lymphoid irradiation and antithymocyte globulin. J Immunol. 1984;132:1013–8.

    CAS  PubMed  Google Scholar 

  63. Levin B, Hoppe RT, Collins G, Miller E, Waer M, Bieber C, et al. Treatment of cadaveric renal transplant recipients with total lymphoid irradiation, antithymocyte globulin, and low-dose prednisone. Lancet. 1985;2:1321–5.

    Article  CAS  PubMed  Google Scholar 

  64. Saper V, Chow D, Engleman ED, Hoppe RT, Levin B, Collins G, et al. Clinical and immunological studies of cadaveric renal transplant recipients given total-lymphoid irradiation and maintained on low-dose prednisone. Transplantation. 1988;45:540–6.

    Article  CAS  PubMed  Google Scholar 

  65. Chow D, Saper V, Strober S. Renal transplant patients treated with total lymphoid irradiation show specific unresponsiveness to donor antigens the mixed leukocyte reaction (MLR). J Immunol. 1987;138:3746–50.

    CAS  PubMed  Google Scholar 

  66. Strober S, Dhillon M, Schubert M, Holm B, Engleman E, Benike C, et al. Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. N Engl J Med. 1989;321:28–33.

    Article  CAS  PubMed  Google Scholar 

  67. Strober S, Benike C, Krishnaswamy S, Engleman EG, Grumet FC. Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity. Transplantation. 2000;69:1549–54.

    Article  CAS  PubMed  Google Scholar 

  68. Millan MT, Shizuru JA, Hoffmann P, Dejbakhsh-Jones S, Scandling JD, Grumet FC, et al. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation. 2002;73:1386–91.

    Article  PubMed  Google Scholar 

  69. Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Millan MT, Shizuru JA, et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med. 2008;358:362–8.

    Article  CAS  PubMed  Google Scholar 

  70. Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Sarwal M, Millan MT, et al. Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transpl. 2012;12:1133–45.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Immunology and Rheumatology, Stanford University School of Medicine, CCSR Building, Room 2215-C, 269 Campus Drive, Stanford, CA, 94305-5166, USA

    Samuel Strober

Authors
  1. Samuel Strober
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samuel Strober.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strober, S. Path to clinical transplantation tolerance and prevention of graft-versus-host disease. Immunol Res 58, 240–248 (2014). https://doi.org/10.1007/s12026-014-8502-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-014-8502-7

Keywords

Search

Navigation